Oral trazodone results in quantifiable sedation but does not result in a xylazine-sparing effect in healthy adult horses
American Journal of Veterinary Research · 2024
DOI: 10.2460/ajvr.24.07.0185 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2024. Verfasst von William E Swanton und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI. Hauptthemen laut MEDLINE: Trazodone, Xylazine, Cross-Over Studies, Hypnotics and Sedatives. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE To evaluate sedation and IV xylazine requirements to achieve 45% of baseline head height above ground measurements following oral (PO) administration of 2 trazodone dosages. METHODS 8 healthy, adult mares of various weights and breeds belonging to a university teaching herd were utilized in a blinded, crossover study design. Horses were randomly assigned to 1 of 3 PO treatments: control (no trazodone), trazodone at 3 mg/kg (low dose [LD]), or trazodone at 6 mg/kg (high dose [HD]). Before treatment, cardiac auscultation, EquiSed sedation score, and head height above ground (HHAG; cm) measurements were performed (baseline) followed by feeding of the treatment mixture. After 120 minutes, sedation score and HHAG were recorded. Xylazine was administered IV (0.25 mg/kg bolus followed by 0.1 mg/kg/min) until HHAG reached 45% of baseline or a total dose of 1 mg/kg was reached. Individual data for xylazine dosage, sedation scores, and HHAG were analyzed using mixed linear models with repeated measures. RESULTS Sedation scores were significantly improved (LD, P = .045; HD, P = .01) and HHAG was lowered (LD, P = .045; HD, P = .09) by trazodone administration. Xylazine dose requirements were increased by LD trazodone administration (increase of 0.26 ± 0.26 mg/kg; P = .03) and unchanged by HD (increase of 0.13 ± 0.25 mg/kg; P = .38). CONCLUSIONS Oral trazodone administration increases quantifiable sedation in horses. Xylazine requirements are significantly increased by LD trazodone administration. CLINICAL RELEVANCE Oral administration of LD trazodone may increase xylazine requirements. Further clinical studies are required to fully assess the clinical relevance of this finding on other parameters such as cardiovascular physiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI.
- Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI.
ORCID-Profile: Carrie Schroeder
Zitieren
APA
Swanton, W. E., Johnson, R., Zhao, Q., & Schroeder, C. (2024). Oral trazodone results in quantifiable sedation but does not result in a xylazine-sparing effect in healthy adult horses. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.07.0185
Vancouver
Swanton WE, Johnson R, Zhao Q, Schroeder C. Oral trazodone results in quantifiable sedation but does not result in a xylazine-sparing effect in healthy adult horses. American Journal of Veterinary Research. 2024. doi:10.2460/ajvr.24.07.0185
BibTeX
@article{Swanton2024,
author = {Swanton, William E and Johnson, Rebecca and Zhao, Qianqian and Schroeder, Carrie},
title = {Oral trazodone results in quantifiable sedation but does not result in a xylazine-sparing effect in healthy adult horses},
journal = {American Journal of Veterinary Research},
year = {2024},
doi = {10.2460/ajvr.24.07.0185}
}
EUVIMED